ConductScience.org, home

Paper25868976

Tyrosine-protein phosphatase non-receptor type 12 expression is a good prognostic factor in resectable non-small cell lung cancer.

Cao X and 8 others. Oncotarget, 2015. Cited by 20 papers, by iCite.

Cite this record

ConductScience Library. Tyrosine-protein phosphatase non-receptor type 12 expression is a good prognostic factor in resectable non-small cell lung cancer. Papers, record 25868976. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/25868976

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Tyrosine-protein phosphatase non-receptor type 12 expression is a good prognostic factor in resectable non-small cell lung cancer.
PubMed
Journal
Oncotarget
PubMed
Year
2015
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
20
iCite
Relative citation ratio, by iCite
0.59
iCite
Revised in PubMed
2018-11-13
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Cao XXun
2Chen YZYan-Zhen
3Luo RZRuo-Zhen
4Zhang LLin
5Zhang SLSong-Liang
6Zeng JJun
7Jiang YCYu-Chuan
8Han YJYu-Jing
9Wen ZSZhe-Sheng

Source PubMed

Download CSV of authors

Topics28

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Biomarkers, TumorMajor topic
Carcinoma, Non-Small-Cell LungMajor topic
Lung NeoplasmsMajor topic
Protein Tyrosine Phosphatase, Non-Receptor Type 12Major topic
Adult
Aged
Aged, 80 and over
Blotting, Western
Chi-Square Distribution
China
Disease Progression
Disease-Free Survival
Female
Humans
Immunohistochemistry
Kaplan-Meier Estimate
Male
Middle Aged
Multivariate Analysis
Neoplasm Recurrence, Local
Pneumonectomy
Predictive Value of Tests
Proportional Hazards Models
Retrospective Studies
Risk Factors
Time Factors
Tissue Array Analysis
Treatment Outcome

Source PubMed

Download CSV of topics

References32

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
121376233Activation of multiple proto-oncogenic tyrosine kinases in breast cancer via loss of the PTPN12 phosphatase.Cell2011https://conductscience.org/library/papers/21376233PubMed
221307310The pINDUCER lentiviral toolkit for inducible RNA interference in vitro and in vivo.Proc Natl Acad Sci U S A2011https://conductscience.org/library/papers/21307310PubMed
37509295Chromosomal localization of the protein tyrosine phosphatase G1 gene and characterization of the aberrant transcripts in human colon cancer cells.FEBS Lett1994https://conductscience.org/library/papers/7509295PubMed
422547449Folate receptor alpha expression in lung cancer: diagnostic and prognostic significance.Oncotarget2012https://conductscience.org/library/papers/22547449PubMed
514670044Stable-isotope dimethyl labeling for quantitative proteomics.Anal Chem2003https://conductscience.org/library/papers/14670044PubMed
617057753Protein tyrosine phosphatases: from genes, to function, to disease.Nat Rev Mol Cell Biol2006https://conductscience.org/library/papers/17057753PubMed
715975092Regulation of FAK Ser-722 phosphorylation and kinase activity by GSK3 and PP1 during cell spreading and migration.Biochem J2005https://conductscience.org/library/papers/15975092PubMed
815064725Gene expression-based, individualized outcome prediction for surgically treated lung cancer patients.Oncogene2004https://conductscience.org/library/papers/15064725PubMed
921996732TOPK/PBK promotes cell migration via modulation of the PI3K/PTEN/AKT pathway and is associated with poor prognosis in lung cancer.Oncogene2012https://conductscience.org/library/papers/21996732PubMed
1019269802Tyrosine phosphorylation: thirty years and counting.Curr Opin Cell Biol2009https://conductscience.org/library/papers/19269802PubMed
1123212450PTPN12 controls PTEN and the AKT signalling to FAK and HER2 in migrating ovarian cancer cells.Mol Cell Biochem2013https://conductscience.org/library/papers/23212450PubMed
1215155950Mutational analysis of the tyrosine phosphatome in colorectal cancers.Science2004https://conductscience.org/library/papers/15155950PubMed
1325594031Hypomethylation and increased expression of the putative oncogene ELMO3 are associated with lung cancer development and metastases formation.Oncoscience2014https://conductscience.org/library/papers/25594031PubMed
1419366350Glycogen synthase kinase 3: more than a namesake.Br J Pharmacol2009https://conductscience.org/library/papers/19366350PubMed
1523335087Cancer statistics, 2013.CA Cancer J Clin2013https://conductscience.org/library/papers/23335087PubMed
1611252954Untangling the ErbB signalling network.Nat Rev Mol Cell Biol2001https://conductscience.org/library/papers/11252954PubMed
1721823119The role of focal adhesion kinase catalytic activity on the proliferation and migration of squamous cell carcinoma cells.Int J Cancer2012https://conductscience.org/library/papers/21823119PubMed
189662379Tissue microarrays for high-throughput molecular profiling of tumor specimens.Nat Med1998https://conductscience.org/library/papers/9662379PubMed
1925344919High Id1 expression, a generally negative prognostic factor, paradoxically predicts a favorable prognosis for adjuvant paclitaxel plus cisplatin therapy in surgically treated lung cancer patients.Oncotarget2014https://conductscience.org/library/papers/25344919PubMed
2018701488Glycogen synthase kinase-3 inhibition induces glioma cell death through c-MYC, nuclear factor-kappaB, and glucose regulation.Cancer Res2008https://conductscience.org/library/papers/18701488PubMed

See all 32 referencesDownload CSV of references

Cited by12

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 20 citations.

PMIDTitleJournalYearIn PapersSource
37333450PTPN12 down-regulated by miR-146b-3p gene affects the malignant progression of laryngeal squamous cell carcinoma.Open Med (Wars)2023https://conductscience.org/library/papers/37333450PubMed
35957898Critical roles of PTPN family members regulated by non-coding RNAs in tumorigenesis and immunotherapy.Front Oncol2022https://conductscience.org/library/papers/35957898PubMed
34784010Protein tyrosine phosphatase non-receptor type 12 (PTPN12), negatively regulated by miR-106a-5p, suppresses the progression of hepatocellular carcinoma.Hum Cell2022https://conductscience.org/library/papers/34784010PubMed
33292053Expression and clinical significance of PTPN12 in clear cell renal cell carcinoma.J Int Med Res2020https://conductscience.org/library/papers/33292053PubMed
32541467Progress in the correlation between PTPN12 gene expression and human tumors.Medicine (Baltimore)2020https://conductscience.org/library/papers/32541467PubMed
31900205Two-hybrid screening of FAM13A protein partners in lung epithelial cells.BMC Res Notes2020https://conductscience.org/library/papers/31900205PubMed
31606028High-level expression of protein tyrosine phosphatase non-receptor 12 is a strong and independent predictor of poor prognosis in prostate cancer.BMC Cancer2019https://conductscience.org/library/papers/31606028PubMed
29872503Combined mTOR and MEK inhibition is an effective therapy in a novel mouse model for angiosarcoma.Oncotarget2018https://conductscience.org/library/papers/29872503PubMed
29744371Proteomic Identification of Heat Shock-Induced Danger Signals in a Melanoma Cell Lysate Used in Dendritic Cell-Based Cancer Immunotherapy.J Immunol Res2018https://conductscience.org/library/papers/29744371PubMed
29578538Combinatorial inhibition of PTPN12-regulated receptors leads to a broadly effective therapeutic strategy in triple-negative breast cancer.Nat Med2018https://conductscience.org/library/papers/29578538PubMed
29278368Structure and Molecular Dynamics Simulations of Protein Tyrosine Phosphatase Non-Receptor 12 Provide Insights into the Catalytic Mechanism of the Enzyme.Int J Mol Sci2017https://conductscience.org/library/papers/29278368PubMed
26391955Loss of PTPN12 Stimulates Progression of ErbB2-Dependent Breast Cancer by Enhancing Cell Survival, Migration, and Epithelial-to-Mesenchymal Transition.Mol Cell Biol2015https://conductscience.org/library/papers/26391955PubMed

Download CSV of cited by

Genes11

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/25868976

GET https://conductscience.org/api/papers/v1/25868976/references?page=2